Featured Research

from universities, journals, and other organizations

Dendritic Cell Immunotherapy May Provide Cancer Patients With A Vaccine To Combat Malignant Brain Tumors

Date:
January 25, 1999
Source:
Cedars-Sinai Medical Center
Summary:
Dendritic cell immunotherapy, a process that uses a vaccine derived from a patient's own cells to fight malignant cells, is being used to treat brain tumors at Cedars-Sinai Medical Center in Los Angeles. The clinical protocol is based on research done in the laboratory at Cedars-Sinai, and was used for the first time in patient treatment on May 11, 1998, at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute.

Los Angeles (January 21, 1999) -- Dendritic cell immunotherapy, a process that uses a vaccine derived from a patient's own cells to fight malignant cells, is being used to treat brain tumors at Cedars-Sinai Medical Center in Los Angeles. The clinical protocol is based on research done in the laboratory at Cedars-Sinai, and was used for the first time in patient treatment on May 11, 1998, at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute.

Related Articles


According to Keith Black, M.D., principal investigator on the project and one of eight physicians and scientists who have been researching dendritic cell immunotherapy, foreign proteins are taken from a tumor after surgical removal. These proteins are introduced to antigen presenting (or dendritic) cells taken from the patient's blood and grown in a Petri dish. The new dendritic cells, when re-injected into the patient, are intended to work like a vaccine, recognizing and destroying the lingering malignant tumor cells. Several such injections are typically scheduled over a six-week period.

Barbara Boyajian was among the first patients to undergo the experimental procedure, having been diagnosed in early June 1998 with glioblastoma multiforme, one of the most aggressive types of brain tumor. She first noticed a problem when her memory lost its sharpness. Shortly thereafter, she says, she walked into a wall. Thinking she needed glasses, she visited an eye doctor and he suggested she schedule an MRI. The malignant tumor was diagnosed and confirmed by three medical opinions. "I ended up in Dr. Black's hands, which was a blessing," says Boyajian.

Dr. Black and his team removed the tumor on July 23, 1998, and a six-week course of radiation therapy followed. Dendritic cell immunotherapy, initiated on Nov. 16, was completed on Dec. 30. Boyajian's positive outlook helped her get through a difficult time. She feels fine now and returns to the Neurosurgical Institute only for follow-up lab work and MRIs. "We're on this side of the tracks," she says, "and we're real excited about it and I have a lot of support from my family and my friends. And I have a tremendous amount of faith."

Dendritic cell immunotherapy has been approved by the Food & Drug Administration for Phase I study and has been used in treating other types of tumors. Other Cedars-Sinai Medical Center physicians and scientists involved in the research include: John Yu, M.D.; Christopher Wheeler, Ph.D.; Reid Thompson, M.D.; Brian Pikul, M.D.; Paul Zeltzer, M.D.; Divina Nacis, R.N.; and Mary Riedinger, R.N.


Story Source:

The above story is based on materials provided by Cedars-Sinai Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Cedars-Sinai Medical Center. "Dendritic Cell Immunotherapy May Provide Cancer Patients With A Vaccine To Combat Malignant Brain Tumors." ScienceDaily. ScienceDaily, 25 January 1999. <www.sciencedaily.com/releases/1999/01/990125073302.htm>.
Cedars-Sinai Medical Center. (1999, January 25). Dendritic Cell Immunotherapy May Provide Cancer Patients With A Vaccine To Combat Malignant Brain Tumors. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/1999/01/990125073302.htm
Cedars-Sinai Medical Center. "Dendritic Cell Immunotherapy May Provide Cancer Patients With A Vaccine To Combat Malignant Brain Tumors." ScienceDaily. www.sciencedaily.com/releases/1999/01/990125073302.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins